Backed by a strong research on the nutritional deficiencies in cancer patients in India, Esperer BioResearch today, launched 2 health supplements. The initiative can benefit approximately 2.25 million people living with Cancer in India.
Read More
A recently released ICMR study says the prevalence of diabetes is likely to rise among those of low socio-economic status in urban and rural areas. By partnering with technology providers, the public healthcare system can prevent the onset of diabetes in people and also delay limb, nerve and organ diseases in those who have contracted it.
Read More
Data from an on-going study by Roche and Wellthy Therapeutics presented at the American Diabetes Association’s 79th Annual Scientific Sessions shows improvement in blood glucose levels. Harnessing data collected through medical devices and applying digital therapeutics enhances self-management practices among diabetes patients. Potential to reduce physician burden and improve diagnosis accuracy by capturing patient data in a timely manner.
Read More
The new HD grid mapping catheter is sensor enabled and facilitates improved data collection, supporting optimal treatment for patients with complex cardiac arrhythmias. First-of-its-kind grid configuration is designed to capture data in multiple directions to create high-density maps of the heart. Novel mapping catheter complements Abbott’s other cardiac mapping system and expands the advanced cardiac mapping portfolio.
Read More
Transasia Bio-Medicals' Sikkim manufacturing plant will be the largest Indian plant for the firm. It would also be Northeast’s first diagnostics manufacturing facility
Read More
Apollo Hospital, Chennai introduces the first digital PET/CT - Biograph Vision™, which brings new level of precision to PET/CT imaging. The first of its kind digital PET/CT, verifying proton beam therapy and efficacy of treatment for various cancers at early stage. Safeguarding patients from negative side effects, reducing ineffective therapies and saving costs made possible with early response effectively detected through Biograph Vision™
Read More
A new generation of rapid diagnostics that are highly sensitive and enable data management can accelerate the end of malaria. Abbott’s Sanjeev Johar and Malaria No More’s Martin Edlund explain in this opinion piece.
Read More
The company is planning to invest USD 5M for more acquisitions to fuel its aggressive growth plans and become a national brand within the next 24 months
Read More
